Author information from the last article
Jarle Jortveit er ph.d., spesialist i indremedisin og i hjertesykdommer, forsker og overlege ved Hjerteseksjonen, Sørlandet sykehus Arendal. Han leder fagrådet i Norsk hjerteinfarktregister.
Articles by Jarle Jortveit
Secondary prevention with beta-blockers after myocardial infarction
- John Munkhaugen,
- Arnhild Bakken,
- Anna Meta Dyrvig Kristiansen,
- Thor Edvardsen,
- Rune Wiseth,
- Terje Kristian Steigen,
- Henrik Schirmer,
- Alf-Inge Larsen,
- Jarle Jortveit,
- Kjell Vikenes,
- Sigrun Halvorsen,
- Dan Atar
02.02.2026:
Recent studies and meta-analyses show that treatment with beta-blockers improves prognosis after myocardial infarction in patients with mildly reduced left ventricular function, but not in patients with normal function who have no other indications for beta-blockers. The results of these new studies...
Secondary prevention in myocardial infarction patients with known coronary artery disease
- Jarle Jortveit,
- John Munkhaugen,
- Anete Kaldal,
- Sigrun Halvorsen
15.12.2025:
Patients with established coronary artery disease (CAD) have an increased risk of new cardiovascular events, including myocardial infarction and premature death (1, 2). There is a very well-documented risk-reducing effect from implementing lifestyle measures and treatment with antiplatelet drugs...
Data quality in the Norwegian Myocardial Infarction Registry
- Ida Almenning Kiel,
- Ragna Elise Støre Govatsmark,
- Veronica Bendiktsen Berge,
- Kari Krizak Halle,
- Stian Lydersen,
- Cecilie Risøe,
- Bjørn Haug,
- Jarle Jortveit,
- Siri Malm,
- Gard F.T. Svingen,
- Miriam Wiksnes,
- Christian Engelsen Berg-Hansen,
- Lars Håvard Nilsen,
- Espen Ellingsen Moe,
- Kaare Harald Bønaa
26.03.2025:
In Norway, 61 national medical quality registries have been established, based on diagnoses, procedures or services (1). The main purpose of these registries is to contribute to better patient treatment (1, 2). They are also used for research and administration. In many medical fields, the national...
A man in his sixties with acute chest pain
- Helene Brenna Haakonsen,
- Jarle Jortveit,
- Fridtjof Heyerdahl
04.09.2023:
A man in his sixties was admitted to a busy emergency department with acute chest pain and elevated troponin. Only after invasive coronary angiography revealed normal findings did the team on duty have to acknowledge that the patient himself had made the correct non-cardiac diagnosis. The patient...
Pharmacy-dispensed drugs for secondary prevention after myocardial infarction
- Jarle Jortveit,
- Sigrun Halvorsen,
- Jørund Langørgen
09.03.2020:
Each year, approximately 13 000 Norwegians are hospitalised with acute myocardial infarction (1). Patients with established coronary artery disease are at increased risk of further cardiovascular events and premature mortality (2). Patients with a history of myocardial infarction are advised to...
Long-term ECG recording: findings and implications
- Jarle Jortveit,
- Trond Helge Lislevand,
- Lars Rysstad,
- Thomas Dahlslett,
- Benthe Sjøli
10.02.2020:
The first recordings of the heart's electrical impulses were described in the 1870s. Willem Einthoven, with his string galvanometer, played a key part in the development of electrocardiography (ECG), and in 1924 he received the Nobel Prize in Medicine for his work (1). An ECG recording provides a...
Takotsubo syndrome in Sørlandet Hospital Arendal 2010–16
- Pål Gunnes,
- Jacob Thalamus,
- Daniela Melichova,
- Slobodan Calic,
- Ole Johan Jakobsen,
- Tomas Larsen,
- Jarle Jortveit
28.01.2019:
Takotsubo syndrome is an acute heart condition with symptoms, changes in electrocardiography (ECG), rise in infarction markers and left ventricle dysfunction that may be consistent with acute myocardial infarction. In Takotsubo syndrome, however, angiography shows open coronary arteries, and there...
Diagnosis of severe congenital heart defects in Norway 2016
- Jarle Jortveit,
- Gunnar Wik,
- Jostein Strand Ødegaard,
- Vasilis Sitras,
- Karl Viktor Perminow,
- Henrik Holmstrøm
21.01.2019:
Congenital heart defects are defined as congenital structural abnormalities of the heart and/or major intrathoracic vessels with functional or potential functional significance (1). Heart defects are the most common congenital malformation and affect approximately 1 in 100 live-born children (2)...